Rigel Pharmaceuticals (RIGL) Q2 2024 Earnings

7MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.5
-0.33
-0.17
0

Details

Expected EPS
-0.287966
Actual EPS
-0.5
Surprise EPS
-0.21
Surprise Percent
+73.63%

Description

Rigel Pharmaceuticals (RIGL) has reported earnings of -0.5 per share for Q2 2024.

0 Comments

Share your thoughts